These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 29908288)

  • 1. Pregnancy outcomes after maternal betahistine exposure: A case series.
    Buharalioglu CK; Acar S; Erol-Coskun H; Küçüksolak G; Karadas B; Kaya-Temiz T; Kaplan YC
    Reprod Toxicol; 2018 Aug; 79():79-83. PubMed ID: 29908288
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pregnancy outcomes after maternal use of thiocolchicoside: A case series.
    Kaplan YC; Keskin-Arslan E; Küçüksolak G; Akyol F; Karadas B; Görgel SN; Kaya-Temiz T
    Reprod Toxicol; 2018 Mar; 76():103-108. PubMed ID: 29378258
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pregnancy outcome following maternal exposure to statins: a multicentre prospective study.
    Winterfeld U; Allignol A; Panchaud A; Rothuizen LE; Merlob P; Cuppers-Maarschalkerweerd B; Vial T; Stephens S; Clementi M; De Santis M; Pistelli A; Berlin M; Eleftheriou G; Maňáková E; Buclin T
    BJOG; 2013 Mar; 120(4):463-71. PubMed ID: 23194157
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pregnancy Outcomes During the Clinical Development Program of Cladribine in Multiple Sclerosis: An Integrated Analysis of Safety.
    Giovannoni G; Galazka A; Schick R; Leist T; Comi G; Montalban X; Damian D; Dangond F; Cook S
    Drug Saf; 2020 Jul; 43(7):635-643. PubMed ID: 32447743
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Birth outcomes after inadvertent use of category X drugs contraindicated in pregnancy: Where is the real risk?
    Öztürk Z; Ölmez E; Gürpınar T; Vural K
    Turk J Pediatr; 2018; 60(3):298-305. PubMed ID: 30511543
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Malformation risk of antiepileptic drug exposure during pregnancy in women with epilepsy: Results from a pregnancy registry in South India.
    Thomas SV; Jose M; Divakaran S; Sankara Sarma P
    Epilepsia; 2017 Feb; 58(2):274-281. PubMed ID: 28084641
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epidemiology of isotretinoin exposure during pregnancy.
    Dai WS; LaBraico JM; Stern RS
    J Am Acad Dermatol; 1992 Apr; 26(4):599-606. PubMed ID: 1597546
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pregnancy outcomes following exposure to abatacept during pregnancy.
    Kumar M; Ray L; Vemuri S; Simon TA
    Semin Arthritis Rheum; 2015 Dec; 45(3):351-6. PubMed ID: 26210783
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pregnancy outcome following maternal exposure to pregabalin may call for concern.
    Winterfeld U; Merlob P; Baud D; Rousson V; Panchaud A; Rothuizen LE; Bernard N; Vial T; Yates LM; Pistelli A; Ellfolk M; Eleftheriou G; de Vries LC; Jonville-Bera AP; Kadioglu M; Biollaz J; Buclin T
    Neurology; 2016 Jun; 86(24):2251-7. PubMed ID: 27194385
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Final results from the 16-year sumatriptan, naratriptan, and treximet pregnancy registry.
    Ephross SA; Sinclair SM
    Headache; 2014; 54(7):1158-72. PubMed ID: 24805878
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuraminidase inhibitors during pregnancy and risk of adverse neonatal outcomes and congenital malformations: population based European register study.
    Graner S; Svensson T; Beau AB; Damase-Michel C; Engeland A; Furu K; Hviid A; Håberg SE; Mølgaard-Nielsen D; Pasternak B; Kieler H
    BMJ; 2017 Feb; 356():j629. PubMed ID: 28246106
    [No Abstract]   [Full Text] [Related]  

  • 12. Pregnancy outcomes after maternal exposure to simvastatin and lovastatin.
    Pollack PS; Shields KE; Burnett DM; Osborne MJ; Cunningham ML; Stepanavage ME
    Birth Defects Res A Clin Mol Teratol; 2005 Nov; 73(11):888-96. PubMed ID: 16163683
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Betahistine: hallucinations?
    Prescrire Int; 2015 Nov; 24(165):269. PubMed ID: 26688903
    [No Abstract]   [Full Text] [Related]  

  • 14. Birth defects in a national cohort of pregnant women with HIV infection in Italy, 2001-2011.
    Floridia M; Mastroiacovo P; Tamburrini E; Tibaldi C; Todros T; Crepaldi A; Sansone M; Fiscon M; Liuzzi G; Guerra B; Vimercati A; Vichi F; Vicini I; Pinnetti C; Marconi AM; Ravizza M;
    BJOG; 2013 Nov; 120(12):1466-75. PubMed ID: 23721372
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Isotretinoin exposure and pregnancy outcome: an observational study of the Berlin Institute for Clinical Teratology and Drug Risk Assessment in Pregnancy.
    Schaefer C; Meister R; Weber-Schoendorfer C
    Arch Gynecol Obstet; 2010 Feb; 281(2):221-7. PubMed ID: 19444462
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Delirium in a 73-year-old man after many years of unwise use of betahistine].
    Hoenders HJ; Wilterdink J
    Ned Tijdschr Geneeskd; 2004 Nov; 148(47):2338-41. PubMed ID: 15587054
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Outcomes of drug exposition during pregnancy: Analysis from a teratology information service.
    Lenoir C; Boumaïza S; Ing Lorenzini KR; Boulvain M; Desmeules JA; Rollason V
    Eur J Obstet Gynecol Reprod Biol; 2020 Apr; 247():42-48. PubMed ID: 32058188
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The safety of sumatriptan and naratriptan in pregnancy: what have we learned?
    Cunnington M; Ephross S; Churchill P
    Headache; 2009; 49(10):1414-22. PubMed ID: 19804390
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Outcomes of pregnancies fathered by solid-organ transplant recipients exposed to mycophenolic acid products.
    Jones A; Clary MJ; McDermott E; Coscia LA; Constantinescu S; Moritz MJ; Armenti VT
    Prog Transplant; 2013 Jun; 23(2):153-7. PubMed ID: 23782663
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of graves' disease with antithyroid drugs in the first trimester of pregnancy and the prevalence of congenital malformation.
    Yoshihara A; Noh J; Yamaguchi T; Ohye H; Sato S; Sekiya K; Kosuga Y; Suzuki M; Matsumoto M; Kunii Y; Watanabe N; Mukasa K; Ito K; Ito K
    J Clin Endocrinol Metab; 2012 Jul; 97(7):2396-403. PubMed ID: 22547422
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.